001446337 000__ 03010cam\a2200541Ii\4500
001446337 001__ 1446337
001446337 003__ OCoLC
001446337 005__ 20230310003952.0
001446337 006__ m\\\\\o\\d\\\\\\\\
001446337 007__ cr\un\nnnunnun
001446337 008__ 220501s2022\\\\si\a\\\\o\\\\\001\0\eng\d
001446337 019__ $$a1313517576
001446337 020__ $$a9789811654190$$q(electronic bk.)
001446337 020__ $$a9811654190$$q(electronic bk.)
001446337 020__ $$z9789811654183
001446337 020__ $$z9811654182
001446337 0247_ $$a10.1007/978-981-16-5419-0$$2doi
001446337 035__ $$aSP(OCoLC)1313480026
001446337 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCF$$dUKAHL$$dOCLCQ
001446337 049__ $$aISEA
001446337 050_4 $$aRB155.8
001446337 08204 $$a615.8/95$$223/eng/20220505
001446337 24500 $$aGene delivery /$$cHuayu Tian, Xuesi Chen, editors.
001446337 264_1 $$aSingapore :$$bSpringer,$$c[2022]
001446337 264_4 $$c©2022
001446337 300__ $$a1 online resource :$$billustrations (some color).
001446337 336__ $$atext$$btxt$$2rdacontent
001446337 337__ $$acomputer$$bc$$2rdamedia
001446337 338__ $$aonline resource$$bcr$$2rdacarrier
001446337 4901_ $$aBiomaterial engineering
001446337 500__ $$aIncludes index.
001446337 5050_ $$aOverview on gene therapy -- Cationic liposome -- Functionalized peptide dendrimers -- Bioresponsive poly(amido amine)s -- Cationic polyphosphoesters -- Polysaccharide-based gene carriers -- Polypeptide-based gene carriers -- Fluorinated gene carriers -- Target gene delivery systems -- Cationic helical polypeptides -- Cyclic cationic polymers -- Cationic bolaamphiphile -- Chitosan-functionalized gene carriers -- Charge-reversal gene carriers -- Multifunctional envelope-type nanodevice -- Drug and gene co-delivery systems -- Oral delivery of gene therapy -- Gene therapy for brain diseases.
001446337 506__ $$aAccess limited to authorized users.
001446337 520__ $$aGene delivery is a promising strategy for the specific treatment of numerous gene-associated human diseases by intentionally altering the gene expression in pathological cells. A successful clinical application of gene-based therapy depends on an efficient gene delivery system. Many efforts have been attempted to improve the safety and efficiency of gene-based therapies. Nanoparticles have been proved to be the most promising vehicles for clinical gene therapy due to their tunable size, shape, surface, and biological behaviors. In this volume, the recent developments of nanoparticles for clinical gene therapy will be identified and summarized.
001446337 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed May 5, 2022).
001446337 650_0 $$aGene therapy.
001446337 650_0 $$aBiomedical materials.
001446337 655_0 $$aElectronic books.
001446337 7001_ $$aTian, Huayu,$$eeditor.
001446337 7001_ $$aChen, Xuesi,$$eeditor.
001446337 77608 $$iPrint version: $$z9811654182$$z9789811654183$$w(OCoLC)1260665004
001446337 830_0 $$aBiomaterial engineering.
001446337 852__ $$bebk
001446337 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-16-5419-0$$zOnline Access$$91397441.1
001446337 909CO $$ooai:library.usi.edu:1446337$$pGLOBAL_SET
001446337 980__ $$aBIB
001446337 980__ $$aEBOOK
001446337 982__ $$aEbook
001446337 983__ $$aOnline
001446337 994__ $$a92$$bISE